Evidence map›Paper›PMID 40005446›Full record

ArticleMedicina (Kaunas, Lithuania)2025

Immunological Landscape of Non-Melanoma Skin Neoplasms: Role of CTLA4+IFN-γ+ Lymphocytes in Tumor Microenvironment Suppression.

Silvana Karabatić Knezović, Dora Knezović, Jelena Ban, Antonela Matana, Neira Puizina Ivić, Merica Glavina Durdov, Mladen Merćep, Irena Drmić Hofman

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Silvana Karabatić KnezovićSecondary Medical School Split, 21000 Split, Croatia.
Dora KnezovićLaboratory for Cancer Research, School of Medicine, University of Split, 21000 Split, Croatia.ORCID 0000-0003-3674-4493
Jelena BanFaculty of Biotechnology and Drug Development, University of Rijeka, 51000 Rijeka, Croatia.ORCID 0000-0001-5792-3998
Antonela MatanaUniversity Department of Health Studies, University of Split, 21000 Split, Croatia.
Neira Puizina IvićDepartment of Dermatology, University Hospital of Split, 21000 Split, Croatia.
Merica Glavina DurdovDepartment of Pathology, Forensic Medicine and Cytology, University Hospital of Split, 21000 Split, Croatia.
Mladen MerćepFaculty of Biotechnology and Drug Development, University of Rijeka, 51000 Rijeka, Croatia.
Irena Drmić HofmanUniversity Department of Health Studies, University of Split, 21000 Split, Croatia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CTLA-4 AntigenInterferon-gammaLymphocytesSkin NeoplasmsTumor MicroenvironmentAdultAgedCarcinoma, Squamous CellFemaleHumansKeratoacanthomaMaleMiddle AgedCTLA-4 AntigenCTLA4 protein, humanInterferon-gammaCTLA-4interferon-gammakeratoacanthomanon-melanoma skin neoplasmssquamous cell carcinomawarts

Identifiers

PMID40005446
PMCPMC11857809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.